Trial record 1 of 1 for:
NCT03785340
Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03785340 |
|
Recruitment Status :
Completed
First Posted : December 24, 2018
Results First Posted : June 6, 2022
Last Update Posted : July 18, 2022
|
Sponsor:
Ocugen
Information provided by (Responsible Party):
Ocugen
- Study Details
- Tabular View
- Study Results
- FDAAA 801 Violations
- Disclaimer
- How to Read a Study Record
Information on FDAAA 801 Violations
More Information: Notices of Noncompliance [FDA]
| Available on ClinicalTrials.gov | Issued by FDA | Study Record Submitted | Notice Type | FDAAA 801 Notice |
|---|---|---|---|---|
| August 4, 2022 | August 1, 2022 | June 29, 2022 | Correction Confirmed by FDA | The responsible party has corrected the violation. |
| April 20, 2022 | April 15, 2022 | July 15, 2020 | Violation Identified by FDA | Failure to Submit. The entry for this clinical trial was not complete at the time of submission, as required by law. This may or may not have any bearing on the accuracy of the information in the entry. |